|Institutional Source||Beutler Lab|
|Gene Name||pyruvate dehydrogenase complex, component X|
|Is this an essential gene?||Possibly non essential (E-score: 0.395)|
|Stock #||R2351 (G1)|
|Chromosomal Location||103021075-103073513 bp(-) (GRCm38)|
|Type of Mutation||nonsense|
|DNA Base Change (assembly)||T to A at 103024217 bp|
|Amino Acid Change||Lysine to Stop codon at position 399 (K399*)|
|Ref Sequence||ENSEMBL: ENSMUSP00000011058 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000011058]|
|Predicted Effect||probably null
AA Change: K399*
AA Change: K399*
|Coding Region Coverage||
|MGI Phenotype||FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The pyruvate dehydrogenase (PDH) complex is located in the mitochondrial matrix and catalyzes the conversion of pyruvate to acetyl coenzyme A. The PDH complex thereby links glycolysis to Krebs cycle. The PDH complex contains three catalytic subunits, E1, E2, and E3, two regulatory subunits, E1 kinase and E1 phosphatase, and a non-catalytic subunit, E3 binding protein (E3BP). This gene encodes the E3 binding protein subunit; also known as component X of the pyruvate dehydrogenase complex. This protein tethers E3 dimers to the E2 core of the PDH complex. Defects in this gene are a cause of pyruvate dehydrogenase deficiency which results in neurological dysfunction and lactic acidosis in infancy and early childhood. This protein is also a minor antigen for antimitochondrial antibodies. These autoantibodies are present in nearly 95% of patients with the autoimmune liver disease primary biliary cirrhosis (PBC). In PBC, activated T lymphocytes attack and destroy epithelial cells in the bile duct where this protein is abnormally distributed and overexpressed. PBC eventually leads to cirrhosis and liver failure. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Oct 2009]|
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Pdhx||
(F):5'- CCTTTAGCTGTGCTAGGAAGG -3'
(R):5'- TTAGATCGTCTGTTCTCGAGC -3'
(F):5'- CTGTGCTAGGAAGGCCTAACTAC -3'
(R):5'- AGCTTCCTGTAATTAGTTGGATGACC -3'